Email updates

Keep up to date with the latest news and content from BMC Immunology and BioMed Central.

This article is part of the supplement: Proceedings of Delivery Systems and Current Strategies to Drug Design

Open Access Proceedings

In Silico identification of M. TB proteins with diagnostic potential

Romel Calero1*, Mayelin Mirabal1, Jesús Bouza1, María V Guzmán1, Humberto Carrillo2, Yamilé López1, Mohd Nor Norazmi34, Maria E Sarmiento1 and Armando Acosta1

Author affiliations

1 Finlay Institute, Havana, Cuba

2 Faculty of Sciences and Center for Complexity Sciences, National Autonomous University of Mexico, Mexico City, Mexico

3 School of Health Sciences, Universiti Sains Malaysia, Malaysia

4 Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Malaysia

For all author emails, please log on.

Citation and License

BMC Immunology 2013, 14(Suppl 1):S9  doi:10.1186/1471-2172-14-S1-S9

Published: 25 February 2013

Abstract

TB, caused by Mycobacterium tuberculosis (MTB), is one of the major global infectious diseases. For the pandemic control, early diagnosis with sensitive and specific methods is fundamental. With the advent of bioinformatics’ tools, the identification of several proteins involved in the pathogenesis of TB (TB) has been possible. In the present work, the MTB genome was explored to look for molecules with possible antigenic properties for their evaluation as part of new generation diagnostic kits based on the release of cytokines. Seven proteins from the MTB proteome and some of their combinations suited the computational test and the results suggested their potential use for the diagnosis of infection in the following population groups: Cuba, Mexico, Malaysia and sub-Saharan Africa. Our predictions were performed using public bioinformatics tools plus three computer programs, developed by our group, to facilitate information retrieval and processing.